Sales of Legal Cannabis Products in the North America Accelerating

Friday, June 16, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+ News Commentary

NEW YORK, June 16, 2017 /PRNewswire/ --

A research by Arcview Market

Research forecasts growth will reaccelerate beginning in 2018, as adult-use sales ramp up in Canada, California and Massachusetts along with medical sales
in Florida. That will grow the $6.7 billion market of 2016 at a robust 27% CAGR to $22.6 billion in 2021. The report indicates that the 20+% annual growth rate is likely to continue for many years past 2021 as more states and countries legalize cannabis. Recent data shows that nearly 1.9 million North Americans are legally using cannabis to manage conditions as severe as polymorphic seizures and as common as chronic pain, while millions more are consuming it legally in adult-use states with little or no negative impact. Maple Leaf Green World Inc. (OTC: MGWFF), Aurora Cannabis Inc. (OTC: ACBFF), Canopy Growth Corporation (OTC: TWMJF), Organigram Holdings Inc. (OTC: OGRMF), Aphria Inc. (OTC: APHQF). 

Polls show that 80% of Americans approve of legal access to medical cannabis and 60% approve of full adult-use legalization. Arcview points out that such level of agreement is rare on any policy issue and it's allowing elected o?cials across the political spectrum to start to move past the stigma previously associated with this issue. The biggest political win of the U.S. election, the report claims, came in California, the state that pioneered the modern cannabis policy reform movement in 1996 when voters passed Proposition 215, the Compassionate Care Act. Though voters failed to approve adult-use in 2010, they voted overwhelmingly in 2016 to make adult-use legal in a state that represents the world's sixth-largest economy.

Maple Leaf Green World Inc. (OTCQB: MGWFF) also listed on the TSX Venture Exchange under the ticker symbol MGW. On June 14th the company announced that it has signed up with Paramount Structures Inc. ("PSI") to commence construction immediately on its cannabis cultivation facility located in Telkwa, British Columbia (the "B.C. Facility").

The time schedule presented by PSI indicates that design, engineering and procurement will begin immediately for the B.C. Facility, followed by site preparation in mid-August 2017. The estimated completion date of the building envelope is estimated to occur in early December 2017. The Company and PSI are working in conjunction to finalize the interior design of the B.C. Facility. It is expected that the interior construction and the installation of cultivation equipment and lighting will commence concurrent with completion of the building envelope. Progress reports for the B.C. Facility will be announced and posted on the Company's website when it becomes available.

Health Canada has introduced several improvements that aim to streamline the licensing of medical cannabis producers, which includes prioritizing those applicants with built out schedule and issuing license without prior inspection upon proof of completion of built out. As such, the management of the Company believe that Maple Leaf will be able to successfully obtain the Access to Cannabis for Medical Purposes Regulations (the "ACMPR") license around the end of 2017 as originally planned.

"We are very pleased that we have retained two very capable and experienced consultants; PSI and CCI, to assist us in completing the final stages of obtaining the ACMPR license and for putting us back on track with our time table, despite an unexpected delay in the early part of this year," said Raymond Lai, President & CEO of Maple Leaf.

Aurora Cannabis Inc. (OTCQX: ACBFF) is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR"). On June 8th, Aurora along with Hempco Food and Fiber Inc. provide additional clarification on the call option that Aurora intends to negotiate with the two majority shareholders of Hempco to acquire, in conjunction with the Company's participation in Hempco's private placement, an interest in Hempco of up to 31,872,292 shares of Hempco. Hempco is a provider of premier hemp seed foods for over 15 years.

Canopy Growth Corporation (OTC: TWMJF) is a world-leading diversified cannabis company, offering diverse brands and curated cannabis strain varieties in dried and oil extract forms. Earlier this month, the company welcomed PUF Ventures Inc. ("PUF"), a London-Ontario-based late-stage ACMPR applicant, to its curated CraftGrow line. Pending a license to cultivate and sell cannabis products, PUF will become the fourth company to join CraftGrow. The program accelerates speed to market for newly licensed producers and provides brand and product exposure by selling partner products to the market's largest group of actively registered customers.

Organigram Holdings Inc. (OTCQB: OGRMF) is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. The company recently announced the finalized acquisition of Trauma Healing Centers Incorporated ("THC") with a final transaction date of June 1, 2017. As previously communicated, THC will join the Organigram group thereby consolidating two leading medicinal cannabis players within the industry. THC will continue to operate independently by providing referrals based on client need to any licensed producer in Canada. "We are excited to complete the formal acquisition process and look forward to continuing our working relationship with THC and their staff," said Greg Engel, CEO of Organigram. "Over the past two years, both companies have worked very well together and we're excited to further our work in supporting medical cannabis patients across Canada." 

Aphria Inc. (OTCQB: APHQF) is one of Canada's lowest cost producers, produces, supplies and sells medical cannabis. Recently, the company and Securecom Mobile Inc. ("Liberty") announced the successful first step of their previously announced U.S. expansion strategy. Aphria, through a strategic investment into DFMMJ Investment Ltd. ("DFMMJ"), a special purpose private company, entered into an exclusive Management Agreement with Chestnut Hill Tree Farm, LLC ("Chestnut"). DFMMJ's intends to continue to target, for expansion, key U.S. states that have approved medical use of marijuana and meets its stringent investment criteria. Chestnut is a Florida nursery authorized by the Florida Department of Health, Office of Compassionate Use ("Department"), as a dispensing organization of medical cannabis to patients in need in the State of Florida. Chestnut holds one of seven licenses granted in Florida, which currently represents approximately 14% of the U.S. medical cannabis market with a total estimated market size at maturity, as calculated by ArcView Market Research, of over $1.1 billion.

Please SIGN UP NOW at To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"

Subscribe Now! Watch us report from NYSE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For this release, expects to be compensated four thousand dollars for financial news dissemination and PR services by a third party non affiliate for maple leaf green world inc. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit:

For further information: Media Contact: +1-877-601-1879



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store